about
Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)Structural basis and specificity of human otubain 1-mediated deubiquitinationJmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicingAsparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factorPost-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasionSystemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsLigand amplification in a dynamic combinatorial glycopeptide library.Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionChanges in gene expression associated with FTO overexpression in mice.The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry.Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitorsHuman oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylationAntibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populationsDeubiquitinating enzyme specificity for ubiquitin chain topology profiled by di-ubiquitin activity probesThe human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages.Pharmacological inhibition of FTO.Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated.Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5'-3'-exoribonuclease 2 (XRN2) during respiratory syncytial virus infection.Dynamic assembly of a membrane signaling complex enables selective activation of NFAT by Orai1.Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway.Comparison of CID versus ETD based MS/MS fragmentation for the analysis of protein ubiquitination.Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.Fluorescence-based active site probes for profiling deubiquitinating enzymesThe Chemoselective One-Step Alkylation and Isolation of Thiophosphorylated Cdk2 Substrates in the Presence of Native CysteineP17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolateUse of Modified Clostridium perfringens Enterotoxin Fragments for Claudin Targeting in Liver and Skin CellsGlycomimetic affinity-enrichment proteomics identifies partners for a clinically-utilized iminosugarA conserved ATP- and Scc2/4-dependent activity for cohesin in tethering DNA molecules
P50
Q24304148-5361578F-7FFB-4B04-8477-5AD340423721Q24309375-81AB55CD-388D-4212-92C5-1577AB1F6DC9Q24310337-2E04BC61-8050-4E76-95C1-19A757792DFDQ24319665-1AD523BF-13D4-42B6-BF3B-E2649F191EB4Q24322164-1ED1C723-5A86-4A8B-A63A-935D6F00D641Q27301271-0CFE2F6D-A2B0-4E6A-A769-909C4CF05A4EQ33222057-2C019C7A-1DA6-42CA-B7D1-013CD7C70072Q33576664-1301D940-BAF3-49F8-A05C-38F2C063FAB0Q33632126-A567BA13-EF64-4371-AFE4-88F469F84CA3Q33904028-DDEAEA9A-32AB-41F2-8226-0A80017E6B67Q34123085-EF342026-13A1-4B4D-B49E-BCD5263603FDQ34165761-E954A6FA-4C41-4E6E-BB87-3A0B8E79D135Q34218234-E714DB60-0043-4AFF-B6D9-D2FFFB4A26F4Q34460610-1737925D-7858-494A-A845-5780D5497A64Q34918154-F23334B9-D5FD-48F3-B9C6-E875A1F8A83BQ35056872-B4271165-6562-47B2-A8BD-FA4FADB1EB00Q35543082-7CDA2FAD-9AC3-4A2D-8337-BEF5DA2BF1E0Q35591825-A1F00E1B-CBB7-4256-BC84-45074CEABA07Q35925841-E1F1CAB8-BD7F-4259-8868-347862E11F74Q36498061-DCE633B1-D84D-458F-8FF8-76A82EA6A523Q36799875-59C5E8FF-FFF3-4EBD-B575-80ECF5FB87D0Q37113887-9ADBA7C9-6D86-4C0F-A97A-B4DD1A9A7380Q37607909-A45CD69D-F5D5-4BE1-ABAF-A4800B6F5F50Q38669430-C9091145-72A6-46B3-90C7-1FE0AC524BD5Q38987117-EEE0897C-FA36-4E5A-823D-7E4DD560FF98Q39437160-6B598037-35AF-4429-B051-BFE851137CE7Q43776563-35D6E159-5A74-43BF-8EF8-37EB00BADD42Q45970654-2D8EE777-19A2-4674-A068-C4AF71F2CFDCQ55426344-CAF7D9A1-EA01-40E5-8643-66004D5AAF65Q58214389-379782B9-6A46-4572-A488-2A96C659E4C3Q58214419-6A1C4610-5522-4E04-BC95-92E6816527D4Q58214443-B1028870-AF6A-494A-84E2-FE7DB4C48F33Q90333778-70EE3B2F-5019-4521-8E46-1011CCB964E9Q91583421-CC72E8DA-F680-4DAF-8A47-6B24AE7B5F3AQ91743008-E6C3E700-92C9-40A2-AFEC-B9BA84F8EF40
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Holger B Kramer
@nl
Holger B Kramer
@sl
Holger B. Kramer
@en
Holger B. Kramer
@es
type
label
Holger B Kramer
@nl
Holger B Kramer
@sl
Holger B. Kramer
@en
Holger B. Kramer
@es
prefLabel
Holger B Kramer
@nl
Holger B Kramer
@sl
Holger B. Kramer
@en
Holger B. Kramer
@es
P106
P1153
8881998300
P31
P496
0000-0002-6400-0945